SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paper man who wrote (2275)6/28/1998 2:32:00 AM
From: OLD JAKE JUSTUS   of 2281
 
1998 World Aids Conference, Geneva. Question: Does the world have a drug for Aids treatment that is readily available and readily affordable by all peoples of the world? My answer: It is reported that Reticulose can be mass produced for about 25 cents per ampule. If it is retailed at 50 cents an ampule, would not every person in every country in the world be able to afford Reticulcose at that price?

Of course, some patients would have to be government subsidized. But, it would most certainly be readily available and readily affordable by the various world's Governments and all other peoples, of the world. Reticulcose is the Aids Drug of the future, in my opinion.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News